Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Cycle Pharmaceuticals logo

Cycle Pharmaceuticals

Recent Finacing

Debt

Recent Raise

$25M

Cycle Pharmaceuticals is a biotech developing and commercializing medicines for rare genetic metabolic and neurological disorders, markets NITYR (nitisinone) for hereditary tyrosinemia and provides individualized patient support.

Founded 2012
Massachusetts, United States
51-100
Private
cyclepharma.com

Highlights

Focus Areas

Pharmaceutical

Recent Investors

Deutsche Bank logo

Financials

$25M

Total Raised

1

Funding round

1

Investor


Team

Upgrade to view the team

See the team members at Cycle Pharmaceuticals.